Elevance Health Inc.

NYSE: ELV · Real-Time Price · USD
312.73
3.41 (1.10%)
At close: Aug 19, 2025, 1:56 PM

Elevance Health Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
189.25B 183.12B 176.81B 174.01B 171.72B 171.75B 171.34B 168.62B 165.71B 160.67B 156.59B 153.25B 149.13B 144.35B 138.64B 133.88B 129.22B 124.63B
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
189.25B 183.12B 176.81B 174.01B 171.72B 171.75B 171.34B 168.62B 165.71B 160.67B 156.59B 153.25B 149.13B 144.35B 138.64B 133.88B 129.22B 124.63B
Operating Income
7.07B 7.76B 7.9B 8.3B 8.58B 8.04B 7.71B 7.87B 8.34B 8.02B 7.71B 7.96B 7.82B 8.05B 7.92B 7.14B 5.53B 6.33B
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Income
7.07B 7.76B 7.9B 8.3B 8.58B 8.04B 7.71B 7.87B 8.34B 8.02B 7.71B 7.96B 7.82B 8.05B 7.92B 7.14B 5.53B 6.33B
Net Income
5.36B 5.92B 5.98B 6.42B 6.69B 6.24B 5.99B 6.08B 6.39B 6.18B 5.98B 6.17B 6.07B 6.23B 6.1B 5.52B 4.23B 4.71B
Selling & General & Admin
n/a n/a n/a n/a n/a 4.82B 9.62B 14.18B 18.69B 18.15B 17.69B 17.35B 16.79B 16.33B 15.91B 16.01B 17.37B 17.59B
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
182.19B 175.36B 168.91B 165.72B 163.14B 158.89B 154.01B 146.57B 138.68B 134.5B 131.19B 127.94B 124.52B 119.96B 114.8B 110.74B 106.32B 100.71B
Operating Expenses
182.19B 175.36B 168.91B 165.72B 163.14B 163.71B 163.63B 160.75B 157.37B 152.65B 148.89B 145.29B 141.31B 136.29B 130.71B 126.75B 123.69B 118.31B
Interest Expense
1.32B 1.26B 1.19B 1.1B 1.06B 1.04B 1.03B 1B 954M 901M 851M 822M 810M 807M 798M 789M 786M 782M
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
182.19B 175.36B 168.91B 165.72B 163.14B 163.71B 163.63B 160.75B 157.37B 152.65B 148.89B 145.29B 141.31B 136.29B 130.71B 126.75B 123.69B 118.31B
Income Tax Expense
1.72B 1.86B 1.93B 1.91B 1.9B 1.8B 1.72B 1.75B 1.92B 1.82B 1.74B 1.82B 1.78B 1.85B 1.83B 1.61B 1.29B 1.61B
Shares Outstanding (Basic)
225.8M 226.4M 227.48M 233.03M 232.2M 232.7M 233.07M 235.3M 236.6M 237.5M 237.96M 239.6M 240.7M 241.4M 241.77M 243.4M 244.5M 245M
Shares Outstanding (Diluted)
225.8M 227.2M 231.1M 233.1M 233.4M 234.2M 235.8M 236.5M 237.8M 239.7M 241.2M 242.2M 243.4M 244.4M 245.5M 246M 247.4M 248.2M
EPS (Basic)
23.56 25.75 25.76 27.59 28.71 26.63 25.35 25.32 26.53 25.50 24.54 25.60 25.11 25.64 25.03 22.58 17.26 18.95
EPS (Diluted)
23.50 25.63 25.61 27.43 28.52 26.46 25.17 25.13 26.30 25.24 24.26 25.30 24.81 25.33 24.72 22.28 17.02 18.68
EBITDA
9.87B 10.46B 10.48B 10.82B 11.16B 10.69B 10.49B 10.66B 11.11B 10.7B 10.23B 10.34B 10.1B 10.24B 10.03B 9.16B 7.5B 8.27B
EBIT
8.39B 9.03B 9.09B 9.4B 9.64B 9.08B 8.74B 8.87B 9.29B 8.92B 8.56B 8.78B 8.63B 8.86B 8.72B 7.92B 6.32B 7.11B
Depreciation & Amortization
1.48B 1.44B 1.39B 1.42B 1.52B 1.61B 1.75B 1.79B 1.82B 1.78B 1.68B 1.56B 1.46B 1.38B 1.3B 1.23B 1.19B 1.17B